Randomized Controlled Trials as Topic
"Randomized Controlled Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.
| Descriptor ID |
D016032
|
| MeSH Number(s) |
E05.318.760.250.500.365.500 N05.715.360.775.088.500.387.500 N06.850.520.450.250.250.365.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Randomized Controlled Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Randomized Controlled Trials as Topic".
This graph shows the total number of publications written about "Randomized Controlled Trials as Topic" by people in this website by year, and whether "Randomized Controlled Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 6 | 6 | 12 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 4 | 6 |
| 2003 | 1 | 9 | 10 |
| 2004 | 3 | 8 | 11 |
| 2005 | 2 | 7 | 9 |
| 2006 | 1 | 13 | 14 |
| 2007 | 2 | 9 | 11 |
| 2008 | 0 | 8 | 8 |
| 2009 | 2 | 5 | 7 |
| 2010 | 3 | 7 | 10 |
| 2011 | 4 | 11 | 15 |
| 2012 | 1 | 10 | 11 |
| 2013 | 2 | 5 | 7 |
| 2014 | 2 | 11 | 13 |
| 2015 | 0 | 4 | 4 |
| 2016 | 4 | 12 | 16 |
| 2017 | 2 | 7 | 9 |
| 2018 | 1 | 8 | 9 |
| 2019 | 3 | 11 | 14 |
| 2020 | 4 | 12 | 16 |
| 2021 | 0 | 6 | 6 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 4 | 4 |
| 2025 | 1 | 8 | 9 |
| 2026 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Randomized Controlled Trials as Topic" by people in Profiles.
-
Behavioral telehealth in low-resource primary care settings for anxiety and depression in youth: protocol for a randomized effectiveness-implementation study. Trials. 2026 Jun 03; 27(1).
-
Enhancing capacity in faith-based organizations to implement and sustain multilevel innovations to improve physical activity: study protocol for the faith in action type II hybrid implementation-effectiveness trial. BMC Public Health. 2026 04 10; 26(1).
-
Evaluating the Effectiveness of the Motivational Interviewing-Based Wellness Coaching for Kids and Families (WC4K) Program in Pediatric Obesity Care: Protocol for a Cluster Randomized Pragmatic Trial. JMIR Res Protoc. 2026 Feb 10; 15:e78792.
-
Increased risk of type I errors for detecting heterogeneity of treatment effects in cluster-randomized trials using mixed-effect models. BMC Med Res Methodol. 2026 Jan 12; 26(1):30.
-
The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristics. Contemp Clin Trials. 2026 Feb; 161:108219.
-
Nutrition intervention of groceries for Black residents of Boston to stop hypertension (GoFresh) among adults with or without treated hypertension trial: rationale, design, and guiding domains. Trials. 2025 Dec 03; 26(1):560.
-
Sociodemographic characteristics of patients throughout the recruitment process into a randomized, controlled behavioral trial. Trials. 2025 Nov 18; 26(1):519.
-
Protocol for a Type 3 hybrid effectiveness-implementation cluster randomized trial to evaluate multi-ethnic, multilevel strategies and community engagement to eliminate hypertension disparities in Los Angeles County. Implement Sci. 2025 10 06; 20(1):42.
-
Mindfulness-based mHealth intervention for pregnant black and Latina women at high risk of postpartum depression-the Healthy Mama and Baby study: protocol and data overview for a randomised controlled trial in an integrated healthcare delivery system. BMJ Open. 2025 Sep 10; 15(9):e103064.
-
Risk of self-harm and overdose after starting buprenorphine for opioid use disorder. Gen Hosp Psychiatry. 2025 Sep-Oct; 96:90-96.